Bacteroides fragilis-Induced Intra-Abdominal Abscess in an Experimental Model Treated with Telithromycin (HMR 3647)

Publisher： Karger

E-ISSN： 1421-9794|47|1|43-49

ISSN： 0009-3157

Source： Chemotherapy, Vol.47, Iss.1, 2000-12, pp. : 43-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Efficacy of Moxifloxacin, a New Quinolone, in the Treatment of Experimental Intra-Abdominal Abscesses Induced by Bacteroides fragilis in Mice

By  

Chemotherapy, Vol. 50, Iss. 2, 2004-06 ,pp. : 76-80

Karger

Access to resources Recommend Favorite

Inhibitory and Bactericidal Effects of Telithromycin (HMR 3647, RU 56647) and Five Comparative Antibiotics, Used Singly and in Combination, against Vancomycin-Resistant and Vancomycin-Susceptible Enterococci

By  

Chemotherapy, Vol. 47, Iss. 4, 2001-05 ,pp. : 250-260

Karger

Access to resources Recommend Favorite

Effect of Ravuconazole, a New Triazole Antifungal, in a Rat Intraabdominal Abscess Model

By  

Chemotherapy, Vol. 47, Iss. 5, 2001-09 ,pp. : 377-380

Karger

Access to resources Recommend Favorite

In vitro Bactericidal Activitiesand Morphologic Changes in Escherichia coli and Bacteroides fragilis by Cephalosporins

By  

Chemotherapy, Vol. 44, Iss. 3, 1998-05 ,pp. : 157-163

Karger

Access to resources Recommend Favorite

Treatment Modalities and Antimicrobial Stewardship Initiatives in the Management of Intra-Abdominal Infections

By Hoffmann Charles   Zak Matthew   Avery Lisa   Brown Jack  

Antibiotics, Vol. 5, Iss. 1, 2016-02 ,pp. : 11-11

MDPI

Access to resources Recommend Favorite